ZNF689 and neoplasm: Studies investigating the role of miR-339-5p indicate that it inhibits tumor invasion in breast cancer (16) and in hepatocellular carcinoma by targeting ZNF689 (17, 18); by regulating EMT, it inhibits metastasis of NSCLC (19).